About Form Bio
Form Bio is a company based in Austin (United States) founded in 2022 by Kent Wakeford and Andrew Busey. Form Bio has raised $30 million across 1 funding round from investors including JAZZ Venture Partners and Thomas Tull. Form Bio offers products and services including FORMsight AI, Bioinformatics Platform, and In Silico Assays. Form Bio operates in a competitive market with competitors including DNAnexus, Cytel, Verge Genomics, Metagenomi and Octant, among others.
- Headquarter Austin, United States
- Founders Kent Wakeford, Andrew Busey
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Form Bio, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$30 M (USD)
in 1 rounds
-
Latest Funding Round
$30 M (USD), Series A
Sep 27, 2022
-
Investors
JAZZ Venture Partners
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Form Bio
Form Bio offers a comprehensive portfolio of products and services, including FORMsight AI, Bioinformatics Platform, and In Silico Assays.
AI tool for optimizing gene therapy vector designs
Accelerates computational tasks in biological research
Enables virtual exploration of vector design spaces
People of Form Bio
Unlock access to complete
Funding Insights of Form Bio
Form Bio has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Series A round of $30 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Form Bio
Form Bio has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include JAZZ Venture Partners and Thomas Tull.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Science focused VC firm investing in the US
|
Locked | Locked | Locked | |
|
TT
Thomas Tull |
American billionaire, angel investor, founder of Legendary Entertainment, active in India.
|
Locked | Locked | Locked |
Investor details for Form Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Form Bio
Investment portfolio details for Form Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Form Bio
Detailed financials for Form Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Form Bio Comparisons
Peer comparison for Form Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Form Bio
Form Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Cytel, Verge Genomics, Metagenomi and Octant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Neurodegenerative disease drugs are developed using computational genomics.
|
|
| Locked | Locked | Locked |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| Locked | Locked | Locked |
Human cell interaction platform is provided for drug discovery.
|
|
| Locked | Locked | Locked |
AI-based tools for drug discovery are provided to researchers.
|
Detailed competitors of Form Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Form Bio
Complete news archive for Form Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Form Bio
Form Bio was founded in 2022.
Form Bio is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Kent Wakeford is the current CEO of Form Bio. They have also founded this company.
Form Bio is a funded company, having raised a total of $30M across 1 funding round to date.
Cloud-based data management tool for providers. The company has developed software that assists with data workflow management and optimization. It has features for data processing, collaboration tools, data visualization, and more.
Form Bio's top competitors include DNAnexus, Cytel and Relation Therapeutics.
Form Bio offers FORMsight AI, Bioinformatics Platform, and In Silico Assays.
Form Bio has 2 investors. Key investors include JAZZ Venture Partners, and Thomas Tull.